{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:16:45Z","timestamp":1779196605951,"version":"3.51.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>\n                    This study focuses on the research of the molecular mechanism of myocardial ischemia-reperfusion injury (MIRI) and the exploration of treatment methods. Firstly, through the analysis of differentially expressed genes (DEGs) in 2 datasets, GSE108940 and GSE160516, 229 DEGs were identified. Further, by using the least absolute shrinkage and selection operator regression and random forest analysis, 3 key genes,\n                    <jats:italic toggle=\"yes\">FAS<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PPARA<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">FGF9<\/jats:italic>\n                    , were screened out. To validate the reliability of these genes, their expression levels were observed in the merged set, experimental set, and validation set. It was found that\n                    <jats:italic toggle=\"yes\">FAS<\/jats:italic>\n                    was highly expressed in the MIRI group, while\n                    <jats:italic toggle=\"yes\">PPARA<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">FGF9<\/jats:italic>\n                    were lowly expressed in the MIRI group, and these results were verified in the validation set. In addition, the receiver operating characteristic curve analysis demonstrated that\n                    <jats:italic toggle=\"yes\">FAS<\/jats:italic>\n                    ,\n                    <jats:italic toggle=\"yes\">PPARA<\/jats:italic>\n                    , and\n                    <jats:italic toggle=\"yes\">FGF9<\/jats:italic>\n                    had good diagnostic values, with the area under the curve all &gt;0.8. The study also explored the signaling pathways and molecular mechanisms in MIRI. The Gene Ontology analysis of the DEGs was mainly enriched in responses to interleukin-1, major histocompatibility complex protein complex, and chemokine activity. The Kyoto Encyclopedia of Genes and Genomes enrichment analysis showed that the DEGs were associated with the interaction between viral proteins and cytokines and their receptors, rheumatoid arthritis, and influenza A. The results of cell experiments showed that in the hypoxia\/reoxygenation model, the cell viability decreased, and the contents of cTnI, creatine kinase, and lactate dehydrogenase were relatively high. After the administration of the candidate drugs resveratrol and GW4064, the cell viability was significantly improved, and the contents of cTnI, creatine kinase, and lactate dehydrogenase were reduced, indicating a significant effect on repairing damaged cells. Through Western blotting and immunofluorescence techniques, it was found that resveratrol and GW4064 could significantly decrease the expression of\n                    <jats:italic toggle=\"yes\">FAS<\/jats:italic>\n                    and increase the expression of\n                    <jats:italic toggle=\"yes\">PPARA<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">FGF9<\/jats:italic>\n                    (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.01), suggesting that these drugs may have potential therapeutic effects on MIRI. Overall, this study not only provides a new perspective for understanding the molecular mechanism of MIRI but also offers valuable clues for the development of new treatment strategies.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047443","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:01:56Z","timestamp":1769965316000},"page":"e47443","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Screening and verification of drugs targeting myocardial ischemia-reperfusion injury"],"prefix":"10.1097","volume":"105","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Norinco General Hospital, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhonggen","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Norinco General Hospital, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouhu","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Joint Surgery, Norinco General Hospital, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Trauma, Norinco General Hospital, Xi\u2019an, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Hang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Norinco General Hospital, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"83","DOI":"10.59249\/LSWK8578","article-title":"Arrhythmias after acute myocardial infarction.","volume":"96","author":"Frampton","year":"2023","journal-title":"Yale J Biol Med"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(08)61237-4","article-title":"Acute myocardial infarction.","volume":"372","author":"White","year":"2008","journal-title":"Lancet"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"16","DOI":"10.14797\/mdcj-16-1-16","article-title":"Cardiogenic shock in the setting of acute myocardial infarction.","volume":"16","author":"Kapur","year":"2020","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s15006-019-0223-3","article-title":"Diagnosis and initial management of acute myocardial infarction.","volume":"161","author":"Zeymer","year":"2019","journal-title":"MMW Fortschr Med"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/0735-1097(92)90033-J","article-title":"Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis.","volume":"20","author":"Jacoby","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.tcm.2022.02.005","article-title":"Myocardial ischemia-reperfusion injury and the influence of inflammation.","volume":"33","author":"Algoet","year":"2023","journal-title":"Trends Cardiovasc Med"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"105743","DOI":"10.1016\/j.phrs.2021.105743","article-title":"Role of epigenetic regulation in myocardial ischemia\/reperfusion injury.","volume":"170","author":"Wang","year":"2021","journal-title":"Pharmacol Res"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"114827","DOI":"10.1016\/j.biopha.2023.114827","article-title":"Abnormalities of glucose and lipid metabolism in myocardial ischemia-reperfusion injury.","volume":"163","author":"Tian","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"e2210691","DOI":"10.1002\/adma.202210691","article-title":"siRNA delivery against myocardial ischemia reperfusion injury mediated by reversibly camouflaged biomimetic nanocomplexes.","volume":"35","author":"Zhou","year":"2023","journal-title":"Adv Mater"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1161\/CIRCRESAHA.123.322620","article-title":"Spatial multiplexed protein profiling of cardiac ischemia-reperfusion injury.","volume":"133","author":"Yao","year":"2023","journal-title":"Circ Res"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/bs.afnr.2019.10.003","article-title":"High-throughput sequencing and food microbiology.","volume":"91","author":"Quijada","year":"2020","journal-title":"Adv Food Nutr Res"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/bib\/bbs046","article-title":"A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis.","volume":"14","author":"Dillies","year":"2013","journal-title":"Brief Bioinform"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"103175","DOI":"10.1016\/j.redox.2024.103175","article-title":"circMIRIAF aggravates myocardial ischemia-reperfusion injury via targeting miR-544\/WDR12 axis.","volume":"73","author":"Yin","year":"2024","journal-title":"Redox Biol"},{"key":"R14-20260519","first-page":"2759","article-title":"Mechanism of Shenxiong Glucose Injection against myocardial ischemia-reperfusion injury based on network pharmacology and molecular docking.","volume":"47","author":"Li","year":"2022","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.4239\/wjd.v14.i7.1057","article-title":"Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia\/reperfusion injury with diabetes.","volume":"14","author":"Yang","year":"2023","journal-title":"World J Diabetes"},{"key":"R16-20260519","first-page":"cm1","article-title":"Interleukin-1 (IL-1) pathway.","volume":"3","author":"Weber","year":"2010","journal-title":"Sci Signal"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/CCO.0000000000000869","article-title":"T-cell-engaging antibodies for the treatment of solid tumors: challenges and opportunities.","volume":"34","author":"Baeuerle","year":"2022","journal-title":"Curr Opin Oncol"},{"issue":"Pt 24","key":"R18-20260519","first-page":"5553","article-title":"Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles.","volume":"126","author":"Colombo","year":"2013","journal-title":"J Cell Sci"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4330\/wjc.v10.i10.123","article-title":"T-cells in myocardial infarction: culprit instigators or mere effectors?","volume":"10","author":"Liberale","year":"2018","journal-title":"World J Cardiol"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1006\/smim.1998.0155","article-title":"Fas\/APO-1\/CD95 in health and autoimmune disease: thymic and peripheral aspects.","volume":"10","author":"Moulian","year":"1998","journal-title":"Semin Immunol"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/PL00009973","article-title":"Fas (APO-1\/CD95) mRNA is down-regulated in liver regeneration after hepatectomy in rats.","volume":"35","author":"Kiba","year":"2000","journal-title":"J Gastroenterol"},{"key":"R22-20260519","article-title":"Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model.","author":"Luo","journal-title":"Autophagy"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"e70472","DOI":"10.7554\/eLife.70472","article-title":"Hepatic MIR20B promotes nonalcoholic fatty liver disease by suppressing PPARA.","volume":"10","author":"Lee","year":"2021","journal-title":"Elife"},{"key":"R24-20260519","doi-asserted-by":"crossref","first-page":"e2301166","DOI":"10.1002\/advs.202301166","article-title":"FGF9 recruits \u03b2-catenin to increase hepatic ECM synthesis and promote NASH-Driven HCC.","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/biom12111639","article-title":"FGF9 promotes expression of HAS2 in palatal elevation via the Wnt\/\u03b2-Catenin\/TCF7L2 pathway.","volume":"12","author":"Sun","year":"2022","journal-title":"Biomolecules"},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/ijms20071523","article-title":"Resveratrol and its effects on the vascular system.","volume":"20","author":"Breuss","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"9932218","DOI":"10.1155\/2021\/9932218","article-title":"Effects and mechanisms of resveratrol on aging and age-related diseases.","volume":"2021","author":"Zhou","year":"2021","journal-title":"Oxid Med Cell Longev"},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"911259","DOI":"10.3389\/fcimb.2022.911259","article-title":"GW4064 alters gut microbiota composition and counteracts autism-associated behaviors in BTBR T+tf\/J mice.","volume":"12","author":"Liu","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.bbrc.2021.02.043","article-title":"GW4064 enhances the chemosensitivity of colorectal cancer to oxaliplatin by inducing pyroptosis.","volume":"548","author":"Guo","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/cvr\/cvy093","article-title":"Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.","volume":"114","author":"Xia","year":"2018","journal-title":"Cardiovasc Res"},{"key":"R31-20260519","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.1038\/s41598-022-11761-0","article-title":"Resveratrol blocks retrotransposition of LINE-1 through PPAR \u03b1 and sirtuin-6.","volume":"12","author":"Okudaira","year":"2022","journal-title":"Sci Rep"},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.cmet.2017.03.007","article-title":"Farnesoid X receptor regulation of the NLRP3 inflammasome underlies cholestasis-associated sepsis.","volume":"25","author":"Hao","year":"2017","journal-title":"Cell Metab"},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"2217024","DOI":"10.1080\/2162402X.2023.2217024","article-title":"FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer.","volume":"12","author":"Lu","year":"2023","journal-title":"Oncoimmunology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047443","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:03:57Z","timestamp":1779195837000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047443","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-05-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}